Disease Database

Inquiry

Overview

In the burgeoning field of computer-aided drug design (CADD), the utilization of disease databases has become integral to facilitating the identification and understanding of disease-related molecular targets, pathways, and genetic associations. These comprehensive databases provide a wealth of information, including genetic, phenotypic, and biochemical data, to aid in the rational design and development of therapeutics.

Disease Database List

Disease Database	URL	Descriptions
Online Mendelian Inheritance in Man (OMIM)	http://www.omim.org/	OMIM is a comprehensive database that catalogs information about various inherited diseases and their underlying genetic causes. Research in CADD can greatly benefit from OMIM as it provides detailed information on disease phenotypes, mutant genes, and the associated metabolic pathways. The database enables researchers to identify potential targets for drug discovery and gain insights into the molecular basis of diseases.
PharmGKB	http://www.pharmgkb.org/	PharmGKB is a resource that focuses on the impact of genetic variations on drug response, metabolism, and efficacy. The database integrates genetic, genomic, and drug-related information, allowing researchers to explore the relationships between genetic variations, drug response, and disease outcomes. CADD researchers can leverage PharmGKB to identify potential drug targets based on genomic data, enhancing personalized medicine approaches.
Genetic Association Database (GAD)	http://geneticassociationdb.nih.gov	The Genetic Association Database (GAD) provides a centralized repository of human genetic association studies related to various diseases. It offers valuable information on the association between genetic variations and diseases, including polymorphisms, chromosomal aberrations, and susceptibility genes. CADD researchers can use this database to gather data on disease-associated genes, facilitating target identification and validation for drug discovery.
Therapeutic Target Database (TTD):	http://db.idrblab.org/ttd/	The Therapeutic Target Database (TTD) is an extensive resource that focuses on drug targets and their associated diseases. It includes information on the known therapeutic targets of approved drugs, along with experimental drugs and clinical trial candidates. TTD offers curated data on drug-target interactions, therapeutic agents, target-related pathways, and associated diseases. This database is an invaluable tool for CADD researchers to explore novel targets and assess their potential as drug candidates.

Benefits of Disease Databases in CADD

Target identification and validation: Disease databases enable researchers to identify potential drug targets by providing comprehensive information on disease-causing genes, phenotypes, and genetic associations. This information aids in selecting appropriate targets for drug discovery projects.
Understanding disease mechanisms: Disease databases provide insights into the molecular basis of diseases, including underlying pathways and genetic variations. Such knowledge helps researchers design drugs that can modulate specific disease mechanisms and improve therapeutic outcomes.
Personalized medicine approaches: By integrating genetic and drug response data, disease databases like PharmGKB enable the development of personalized medicine approaches. This assists in tailoring drug treatments for individuals based on their genetic profiles, ultimately leading to improved efficacy and reduced adverse effects.
Facilitating drug repurposing: Disease databases can inform researchers about previously approved drugs or experimental compounds targeting related diseases. This information can guide drug repurposing efforts, saving time and resources in the drug discovery process.

Conclusion

Disease databases play a crucial role in computer-aided drug design by offering researchers a comprehensive and organized repository of disease-related information. OMIM, PharmGKB, GAD, and TTD are prominent examples of such databases, each catering to specific aspects of target identification, genetic associations, and drug information. By leveraging these databases, researchers can accelerate the drug discovery process, understand disease mechanisms, and develop more effective and personalized treatments for complex diseases.

For research use only. Not intended for any clinical use.

Online Inquiry